Resistin as potential biomarker for chronic periodontitis: a systemic review and meta-analysis
Archives of Oral Biology, 2017; 73: 311-320
Researchers found that CP patients were presented with elevated levels of GCF or serum resistin as compared with H individuals. Resistin modulates inflammation in chronic periodontal disease and may be used as surrogate measure to identify subjects at risk for periodontitis. Resistin levels in patients with CP and systemic inflammatory disorders such as diabetes, obesity, or rheumatoid arthritis was not significantly higher than the levels in patients with only CP.